Form 4: Boston Scientific EVP Wendy Carruthers Executes Stock Options Under 10b5-1 Plan
SEC Form 4
Wendy Carruthers, EVP of Human Resources at Boston Scientific, executed stock options and sold shares under a pre-established Rule 10b5-1 trading plan.
Summary
- On March 1, 2024, Wendy Carruthers, EVP of Human Resources at Boston Scientific, executed stock options to acquire 3,066 shares at $17.26 and 1,197 shares at $24.55.
- Carruthers also sold 6,983 shares of common stock at $66.35.
- These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
- Following these transactions, Carruthers beneficially owns 53,788 shares of common stock directly.
- Carruthers also holds options to purchase 27,594 shares at $17.26 and 23,956 shares at $24.55.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. There is no indication of positive or negative sentiment towards the company's prospects.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of Rule 10b5-1 plans allows insiders to trade company stock without being accused of insider trading, as long as the plan is established before any material non-public information is known.
Comparison to Industry Standards
- Executive compensation packages in the medical device industry often include stock options as a significant component.
- The vesting schedules and exercise prices of these options are generally aligned with industry norms to incentivize long-term performance.
- Rule 10b5-1 trading plans are widely used by executives at companies like Medtronic, Abbott, and Stryker to manage their stock holdings in a compliant manner.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares in the open market.
- The execution of stock options is part of the executive's compensation package and is unlikely to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/22/2017 | First anniversary of the grant date for options vesting in four equal annual installments. |
| 02/28/2018 | First anniversary of the grant date for options vesting in four equal annual installments. |
| 11/17/2023 | Date of adoption of the Rule 10b5-1 trading plan. |
| 03/01/2024 | Date of the reported transactions (stock option exercise and sale). |
| 03/04/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.